Long‐term patterns of humoral and cellular response after vaccination against influenza A (H 1 N 1) in patients with hematologic malignancies

J Mariotti, F Spina, C Carniti, G Anselmi… - European Journal of …, 2012 - Wiley Online Library
Objectives The efficacy of a novel vaccine against influenza virus A (H 1 N 1) in patients with
hematologic malignancies is largely unknown. Methods We prospectively evaluated the …
被引用次数：20 相关文章

Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies

J Mariotti, F Spina, C Carniti… - European journal …, 2012 - pubmed.ncbi.nlm.nih.gov
Objectives The efficacy of a novel vaccine against influenza virus A (H1N1) in patients with
hematologic malignancies is largely unknown. Methods We prospectively evaluated the …

Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies.

J Mariotti, F Spina, C Carniti, G Anselmi… - European Journal of …, 2012 - europepmc.org
Objectives The efficacy of a novel vaccine against influenza virus A (H1N1) in patients with
hematologic malignancies is largely unknown. Methods We prospectively evaluated the …

Long term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies

J Mariotti, F Spina, C Carniti, G Anselmi… - EUROPEAN JOURNAL …, 2012 - air.unimi.it
OBJECTIVES: The efficacy of a novel vaccine against influenza virus A (H1N1) in patients
with hematologic malignancies is largely unknown. METHODS: We prospectively evaluated …

Long‐term patterns of humoral and cellular response after vaccination against influenza A (H 1 N 1) in patients with hematologic malignancies

J Mariotti, F Spina, C Carniti, G Anselmi… - European Journal of …, 2012 - infona.pl
Objectives The efficacy of a novel vaccine against influenza virus A (H 1 N 1) in patients with
hematologic malignancies is largely unknown. Methods We prospectively evaluated the …

Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies.

J Mariotti, F Spina, C Carniti, G Anselmi, D Lucini… - 2012 - cabidigitallibrary.org
Objectives: The efficacy of a novel vaccine against influenza virus A (H1N1) in patients with
hematologic malignancies is largely unknown. Methods: We prospectively evaluated the …

Long-term patterns of humoral and cellular response after vaccination against influenza A (H1 N1) in patients with hematologic malignancies.

J Mariotti, F Spina, C Carniti… - European Journal …, 2012 - search.ebscohost.com
Objectives The efficacy of a novel vaccine against influenza virus A (H1 N1) in patients with
hematologic malignancies is largely unknown. Methods We prospectively evaluated the …

Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies

J Mariotti, F Spina, C Carniti, G Anselmi… - EUROPEAN JOURNAL …, 2012 - air.unimi.it
Objectives The efficacy of a novel vaccine against influenza virus A (H1N1) in patients with
hematologic malignancies is largely unknown. Methods We prospectively evaluated the …